184 related articles for article (PubMed ID: 21515045)
1. Synthesis and bioactivity of new Finasteride conjugate.
Shuang Z; Jiazhen W; Lijuan Y; Zhuo L; Dahai Y; Jinfeng L; Jing Y; Yongtao L; En-Si W; Xuexun F
Bioorg Med Chem Lett; 2011 Jun; 21(11):3439-42. PubMed ID: 21515045
[TBL] [Abstract][Full Text] [Related]
2. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.
Zhao XF; Yang Y; Wang W; Qiu Z; Zhang P; Wang B
Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194
[TBL] [Abstract][Full Text] [Related]
3. A 5α-reductase inhibitor, finasteride, increases differentiation and proliferation of embryonal carcinoma cell-derived-neural cells.
Shoae-Hassani A; Sharif S; Verdi J
Med Hypotheses; 2011 Jan; 76(1):11-3. PubMed ID: 20851532
[TBL] [Abstract][Full Text] [Related]
4. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.
Span PN; Völler MC; Smals AG; Sweep FG; Schalken JA; Feneley MR; Kirby RS
J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433
[TBL] [Abstract][Full Text] [Related]
5. New 5alpha-reductase inhibitors: in vitro and in vivo effects.
Pérez-Ornelas V; Cabeza M; Bratoeff E; Heuze I; Sánchez M; Ramírez E; Naranjo-Rodríguez E
Steroids; 2005 Mar; 70(3):217-24. PubMed ID: 15763601
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor.
Yao Z; Xu Y; Zhang M; Jiang S; Nicklaus MC; Liao C
Bioorg Med Chem Lett; 2011 Jan; 21(1):475-8. PubMed ID: 21094046
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
[TBL] [Abstract][Full Text] [Related]
8. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.
Youn DH; Park J; Kim HL; Jung Y; Kang J; Jeong MY; Sethi G; Seok Ahn K; Um JY
Oncotarget; 2017 Feb; 8(6):9500-9512. PubMed ID: 27880726
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of novel unsaturated carboxysteroids as human 5α-reductase inhibitors: a legitimate approach.
Aggarwal S; Thareja S; Bhardwaj TR; Haupenthal J; Hartmann RW; Kumar M
Eur J Med Chem; 2012 Aug; 54():728-39. PubMed ID: 22776417
[TBL] [Abstract][Full Text] [Related]
10. Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5alpha-reductase II.
Pais P
Adv Ther; 2010 Aug; 27(8):555-63. PubMed ID: 20623347
[TBL] [Abstract][Full Text] [Related]
11. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.
Rittmaster RS
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794
[TBL] [Abstract][Full Text] [Related]
12. An overview on 5alpha-reductase inhibitors.
Aggarwal S; Thareja S; Verma A; Bhardwaj TR; Kumar M
Steroids; 2010 Feb; 75(2):109-53. PubMed ID: 19879888
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of bioactive polyheterocyclic ring systems as 5α-reductase inhibitors.
Abdel Hafez NA; Farghaly TA; Al-Omar MA; Abdalla MM
Eur J Med Chem; 2010 Nov; 45(11):4838-44. PubMed ID: 20739104
[TBL] [Abstract][Full Text] [Related]
14. 5alpha-reductase inhibitors/finasteride.
Stoner E
Prostate Suppl; 1996; 6():82-7. PubMed ID: 8630236
[TBL] [Abstract][Full Text] [Related]
15. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
Yamashita A; Hayashi N; Sugimura Y; Cunha GR; Kawamura J
Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride.
Makridakis N; Reichardt JK
J Mol Endocrinol; 2005 Jun; 34(3):617-23. PubMed ID: 15956333
[TBL] [Abstract][Full Text] [Related]
17. Comparative effect of finasteride and dutasteride on chromogranin A levels.
Sciarra A; Salciccia S; Nesi G; Cattarino S; Alfarone A; Gentilucci A; Gentile V
Anticancer Res; 2010 Nov; 30(11):4737-42. PubMed ID: 21115933
[TBL] [Abstract][Full Text] [Related]
18. Anti-androgenic effect of sesquiterpenes isolated from the rhizomes of Curcuma aeruginosa Roxb.
Suphrom N; Pumthong G; Khorana N; Waranuch N; Limpeanchob N; Ingkaninan K
Fitoterapia; 2012 Jul; 83(5):864-71. PubMed ID: 22465508
[TBL] [Abstract][Full Text] [Related]
19. Steroidal pyrazolines and pyrazoles as potential 5α-reductase inhibitors: synthesis and biological evaluation.
Banday AH; Shameem SA; Jeelani S
Steroids; 2014 Dec; 92():13-9. PubMed ID: 25278254
[TBL] [Abstract][Full Text] [Related]
20. The effect of 5alpha-reductase inhibition with finasteride and dutasteride on bone mineral density in older men with benign prostatic hyperplasia.
Mačukat IR; Spanjol J; Orlič ZC; Butorac MZ; Marinovič M; Ćupič DF
Coll Antropol; 2014 Sep; 38(3):835-9. PubMed ID: 25420363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
